Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PROTEINS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
Knowledge base pages for this entity
graph TD
PROTEINS["PROTEINS"]
style PROTEINS fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
PROTEINS -->|"involved_in"| Age_Related_Disease_Risk(Age-Related Disease Risk)
PROTEINS -->|"regulates"| APOPTOSIS(APOPTOSIS)
PROTEINS -->|"references"| SIRT6([SIRT6])
PROTEINS -->|"references"| MMP2([MMP2])
PROTEINS -->|"references"| PYCARD([PYCARD])
PROTEINS -->|"references"| HNRNPA2B1([HNRNPA2B1])
PROTEINS -->|"references"| AQP4([AQP4])
PROTEINS -->|"references"| COX4I1([COX4I1])
PROTEINS -->|"references"| HSPA1A([HSPA1A])
PROTEINS -->|"references"| CREB1([CREB1])
ROS(ROS) -->|"causes"| PROTEINS| Target | Relation | Type | Str |
|---|---|---|---|
| Age-Related Disease Risk | involved_in | phenotype | 0.90 |
| Mortality Risk | risk_factor_for | phenotype | 0.85 |
| Disease Risk | risk_factor_for | phenotype | 0.85 |
| Prostate Cancer Biomarkers | associated_with | biomarker | 0.80 |
| APOPTOSIS | regulates | phenotype | 0.64 |
| AUTOPHAGOSOME | inhibits | concept | 0.50 |
| STRESS GRANULES | activates | concept | 0.50 |
| AMYLOID-β | associated_with | concept | 0.50 |
| α-SYNUCLEIN | associated_with | concept | 0.50 |
| GENE EXPRESSION | regulates | concept | 0.50 |
| CELL PROLIFERATION | associated_with | concept | 0.50 |
| CEREBROSPINAL FLUID | expressed_in | concept | 0.50 |
| LEWY BODY | activates | concept | 0.50 |
| EXTRACELLULAR VESICLES | regulates | concept | 0.50 |
| NUCLEUS | regulates | concept | 0.50 |
| CEREBROSPINAL FLUID | activates | concept | 0.50 |
| METFORMIN | associated_with | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | regulates | concept | 0.50 |
| ENDOTHELIAL CELLS | activates | concept | 0.50 |
| NUCLEUS | associated_with | concept | 0.50 |
| MTOR SIGNALING | activates | concept | 0.50 |
| TEMPORAL LOBE | regulates | concept | 0.50 |
| IL-17 | interacts_with | concept | 0.50 |
| FRONTAL | associated_with | concept | 0.50 |
| TEMPORAL LOBE | associated_with | concept | 0.50 |
| EXTRACELLULAR VESICLES | expressed_in | concept | 0.50 |
| CHOLESTEROL METABOLISM | interacts_with | concept | 0.50 |
| FURIN | associated_with | concept | 0.50 |
| ENDOPLASMIC RETICULUM | activates | concept | 0.50 |
| SELECTIVE AUTOPHAGY | associated_with | concept | 0.50 |
| GSK3 | activates | concept | 0.50 |
| PI3K/AKT SIGNALING | activates | concept | 0.50 |
| STRESS GRANULES | associated_with | concept | 0.50 |
| CHAPERONE-MEDIATED AUTOPHAGY | interacts_with | concept | 0.50 |
| AUTOPHAGOSOME | associated_with | concept | 0.50 |
| RAPAMYCIN | activates | concept | 0.50 |
| CHAPERONE-MEDIATED AUTOPHAGY | activates | concept | 0.50 |
| AUTOPHAGOSOME | regulates | concept | 0.50 |
| AUTOPHAGOSOME | interacts_with | concept | 0.50 |
| B CELLS | interacts_with | concept | 0.50 |
| FIBROBLASTS | activates | concept | 0.50 |
| ENDOPLASMIC RETICULUM | regulates | concept | 0.50 |
| GENE EXPRESSION | activates | concept | 0.50 |
| ISCHEMIC STROKE | expressed_in | concept | 0.50 |
| GENE EXPRESSION | inhibits | concept | 0.50 |
| Neuroprotection | activates | process | 0.50 |
| α-SYNUCLEIN | activates | concept | 0.50 |
| LEWY BODY | inhibits | concept | 0.50 |
| AMYGDALA | associated_with | concept | 0.50 |
| AMYGDALA | activates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ROS | causes | phenotype | 0.64 |
| apoptosis | regulates | process | 0.50 |
| ULK1 | interacts_with | gene | 0.50 |
| SYNCRIP | activates | concept | 0.50 |
| CDC42 | associated_with | gene | 0.50 |
| SYNCRIP | associated_with | concept | 0.50 |
| Neuron | interacts_with | cell_type | 0.50 |
| Pi3K | activates | pathway | 0.50 |
| PKM2 | activates | protein | 0.50 |
| GLYCOLYSIS | activates | pathway | 0.50 |
| MAP2 | interacts_with | gene | 0.50 |
| MAP1B | interacts_with | gene | 0.50 |
| MAP6 | interacts_with | gene | 0.50 |
| MAP6 | regulates | gene | 0.50 |
| Neurogenesis | interacts_with | pathway | 0.50 |
| MICROTUBULES | interacts_with | concept | 0.50 |
| Neuron | associated_with | cell_type | 0.50 |
| NEURONS | associated_with | concept | 0.50 |
| GLUT4 | activates | concept | 0.50 |
| INSULIN | activates | concept | 0.50 |
| NUDEL | interacts_with | protein | 0.50 |
| DYNEIN | interacts_with | protein | 0.50 |
| LIS1 | interacts_with | protein | 0.50 |
| FOXO3 | activates | gene | 0.50 |
| MITOCHONDRIAL DNA | activates | gene | 0.50 |
| MTDNA | activates | gene | 0.50 |
| STROKE | expressed_in | gene | 0.50 |
| ISCHEMIC | expressed_in | concept | 0.50 |
| OCCLUDIN | activates | protein | 0.50 |
| COPD | activates | disease | 0.50 |
| MCOLN1 | inhibits | gene | 0.50 |
| VPS34 | interacts_with | protein | 0.50 |
| ENDOSOMES | activates | concept | 0.50 |
| PIEZO1 | associated_with | gene | 0.50 |
| PIEZO2 | associated_with | gene | 0.50 |
| NRF2 | associated_with | gene | 0.50 |
| TFAM | activates | gene | 0.50 |
| PGC-1Α | activates | protein | 0.50 |
| NRF2 | regulates | gene | 0.50 |
| UBIQUITIN | associated_with | protein | 0.50 |
| UBIQUITIN | expressed_in | protein | 0.50 |
| CELL SURVIVAL | expressed_in | concept | 0.50 |
| mitophagy | regulates | pathway | 0.50 |
| SOX2 | regulates | gene | 0.50 |
| KLF4 | regulates | gene | 0.50 |
| MIRNAS | regulates | gene | 0.50 |
| OCT4 | regulates | concept | 0.50 |
| Neuroinflammation | activates | process | 0.50 |
| oxidative stress | activates | phenotype | 0.50 |
| MCOLN1 | activates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| s:** - Test MCU overexpression specifically in layer II neurons in hea | falsification | Neurodegeneration | 0.400 | 0.50 | mouse | proposed | $200,000 |
| Proposed experiment from debate on Mitochondrial transfer between astr | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Proposed experiment from debate on Mitochondrial transfer between astr | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| AAV-LRRK2 IND-Enabling Study Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
| Axonal Transport Dysfunction Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Gap Junction Dysfunction Validation in Parkinson's Disease | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| AAV-LRRK2 Gene Therapy IND-Enabling Study Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in Parkinson' | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Selective Neuronal Vulnerability to Aging — Mapping Why Specific Neuro | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Synaptic Mitochondrial Resilience Enhancement for Parkinson's Disease | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| KIF5A de novo mutation associated with myoclonic seizures and neonatal onset pro [PMID:27414745] | Rydzanicz M, Jagła M, Kosinska J, Tomasi | Clin Genet | 2017 | 1 |
| TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and [PMID:23395375] | van Spronsen M, Mikhaylova M, Lipka J, S | Neuron | 2013 | 1 |
| Delineation of the TRAK binding regions of the kinesin-1 motor proteins. [PMID:24161670] | Randall TS, Moores C, Stephenson FA | FEBS Lett | 2013 | 1 |
| Therapeutic developments in pancreatic cancer. [PMID:37798442] | ["Hu Z", "O'Reilly E"] | Nature reviews. Gastroenterolo | 2024 | 0 |
| Defining treatment-resistant depression. [PMID:31638723] | ["Gaynes B", "Lux L", "Gartlehner G", "A | Depression and anxiety | 2020 | 0 |
| Emerging trends in global freshwater availability. [PMID:29769728] | ["Rodell M", "Famiglietti J", "Wiese D", | Nature | 2018 | 0 |
| Acute Heart Failure: Definition, Classification and Epidemiology. [PMID:28785969] | ["Kurmani S", "Squire I"] | Current heart failure reports | 2017 | 0 |
| Invasive ductal carcinoma: relationship between pathological characteristics and [PMID:28658335] | ["Aquino R", "Vasques P", "Cavalcante D" | Revista do Colegio Brasileiro | 2017 | 0 |
| The Impact of Intergenerational Cultural Dissonance on Alcohol Use Among Vietnam [PMID:26598062] | ["Kane J", "Johnson R", "Robinson C", "J | The Journal of adolescent heal | 2016 | 0 |
| A proliferative burst during preadolescence establishes the final cardiomyocyte [PMID:24813607] | ["Naqvi N", "Li M", "Calvert J", "Tejada | Cell | 2014 | 0 |
| Family medicine match rate increases slightly. [PMID:22585896] | Sheri Porter | Annals of family medicine | 2012 | 0 |
| Human plasma glycome in attention-deficit hyperactivity disorder and autism spec [PMID:20974899] | ["Pivac N", "Knezevi\u0107 A", "Gornik O | Molecular & cellular proteomic | 2011 | 0 |
| The Crumbs complex: from epithelial-cell polarity to retinal degeneration. [PMID:19625503] | ["Bulgakova N", "Knust E"] | Journal of cell science | 2009 | 0 |
| CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell [PMID:18971423] | ["Landsman L", "Bar-On L", "Zernecke A", | Blood | 2009 | 0 |
| GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins [PMID:15644324] | Brickley K, Smith MJ, Beck M, Stephenson | The Journal of biological chem | 2005 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PROTEINS in their description or question text
Score: 0.489 · neurodegeneration · 2026-04-25
Electrostatic bridging by glycans and low-abundance proteins preserves disease-relevant fibril architecture.
Score: 0.474 · proteomics · 2026-04-25
CHIP E3 Ligase Enhancement to Target Synaptic Proteins for Degradation
Score: 0.122 · molecular-biology · 2026-04-18
## Mechanistic Overview Alectinib Binds Mitochondrial C1q-like Proteins (C1QDC1) Rather Than Circulating C1q starts from
Score: 0.000 · unknown disease · 2026-04-28
Engineered decoy proteins with multiple condensate-targeting domains could sequester pathological proteins away from har
Score: 0.000 · unknown disease · 2026-04-28
Location-specific PROTAC-like molecules that selectively degrade proteins appearing in incorrect subcellular compartment
Score: 0.000 · unknown disease · 2026-04-28
Enhancing autophagy specifically in reactive astrocytes through targeted mTOR inhibition could accelerate clearance of a